Find clinical trials for Non-Small-Cell Lung Cancer in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Durham, NC, USA:
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Chapel Hill, North Carolina, United States and 43 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Durham, North Carolina, United States and 126 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Durham, North Carolina, United States and 230 other locations
This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...
Phase 2
Durham, North Carolina, United States and 157 other locations
with NKTR-255 and anti-PD1 therapy for subjects with refractory non-small cell lung cancer.The purpose o...
Phase 1
Raleigh, North Carolina, United States
This is a Phase III, randomised, double-blind, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) in combina...
Phase 3
Greensboro, North Carolina, United States and 227 other locations
The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy ...
Phase 3
Henrico, Virginia, United States and 225 other locations
phase 2 dose (RP2D) of REGN5093 in patients with MET-altered Non-small cell lung cancer (NSCLC).The prim...
Phase 1, Phase 2
Durham, North Carolina, United States and 29 other locations
The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patient...
Phase 3
Chapel Hill, North Carolina, United States and 127 other locations
phase II dose (RP2D). Subjects with selected solid tumors including non-small cell lung cancer (NSCLC) w...
Phase 1
Durham, North Carolina, United States and 1 other location
Clinical trials
Research sites
Resources
Legal